She served next as a partner at Optum Ventures. The median estimated compensation for executives at Centene Corporation including base salary and bonus is $235,905, or $113 per hour. ST. LOUIS, March 22, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to:our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully;restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. The average Centene Corporation executive compensation is $233,970 a year. Clayton-based Centene Corp. has appointed its vice board chair Sarah London as its new CEO. Sarah London Age : 42 Public asset : 24,128,130 USD Country of residence : Unknown Linked companies : Centene Corporation Biography of Sarah London Presently, Sarah London is President-Health Care Enterprises at Centene Corp. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. Over the last 19 years, insiders at Centene have traded over $220,031,916 worth of Centene stock and bought 89,005 units worth $5,026,837 Forward-Looking StatementsAll statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Centene, which sells an array of government subsidized health insurance including Obamacare, has been working for much of this year on a permanent successor to Neidorff, who in December announced his plan to retire later this year.London takes over a company that is a national player among the biggest . In Illinois alone, over the same period, Centene grew from approximately 16,300 members in the Chicago area to nearly 1 million members in every county in the state. Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Prior to Optum Ventures, Ms. London served as Chief Product Officer for Optum Analytics, the business unit responsible for driving strategy and commercialization of Optum's integrated data and analytics solutions into the provider, payer and life sciences markets. Ms. London has spent her career at the forefront of innovation in healthcare. London takes over a company that is a national player among the biggest names in health insurance, particularly in working with states to manage their Medicaid health insurance for poor Americans and providing individual coverage under the Affordable Care Act. Managed care members jumped 1.1 million to 26.6 million. Biography. Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Company, and . Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, after the date hereof. Executive Compensation Data Year: Trend Analysis As at CENTENE CORP, made $0 in total compensation. All proxy statements are public filings made available to the general public by the SEC. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Share Your Design Ideas, New JerseysMurphy Defends $10 Billion Rainy Day Fund as States Economy Slows, This Week in Crypto: Ukraine War, Marathon Digital, FTX. Centene Corporation and Brent Layton as President and Chief Operating Officer of I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. March 22, 2022 Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. Together, we can deliver innovative, integrated, and equitable care that meets our members where they live and exceeds their expectations. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Cigna fell less than 0.3% to close at $234.02, giving. David Westin speaks with top names in finance about the week's biggest issues on Wall Street. Centene has promoted Sarah London, the health insurance companys current board vice chair, to the job as Chief Executive Officer, succeeding the retiring Michael Neidorff, the company said Tuesday afternoon. . Sarah London 67% approve of Sarah London's performance Founded 1984 Company size more than 10,000 Revenue more than $10B (USD) Industry Healthcare Insurance Headquarters 7700 Forsyth Blvd. Sarah London was named Centene CEO, taking over from Michael Neidorff, who will remain the company's chairman. ", Drew Asher, Centene's Chief Financial Officer, said, "Sarah brings a modern vision to the helm of one of this country's most important healthcare companies. The Board and I are confident that she is the right visionary leader to increase value for our shareholders and author the next chapter of Centene's growth. o.. Centene Joins Pro Football Hall of Fame for Military Salute to Service in Arizona. All rights reserved. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. 831 salaries for 310 jobs at Centene in Santa Fe, TX. 396 Ratings. Ms. London began her healthcare career at Health Leads, a nationally-recognized social enterprise that partners with healthcare organizations to address social determinants of health by connecting patients to the community-based resources needed to support high-quality, cost-effective health outcomes. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. Nov 2013 - Mar 20173 years 5 months. Since her appointment to lead the company in 2022, she has focused on developing a culture of transformation, implementing artificial intelligence and machine learning solutions to better improve health and quality of life for Centenes members. She later earnedan MBA from the University of Chicago. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. All content is posted anonymously by employees working at Centene. In her management role, Ms. London led the Company's technology and digital strategy in addition to running the Health Care Enterprises and Specialty divisions, Corporate Strategy, Quality Operations, Internal Audit, Compliance and Risk Management. Magna Cum Laude in History & Literature from Harvard College, where she played Division I tennis. Her focus has been advancing integrated, value-based care models through the development and application of data-driven insights and technology. YEAR. Author of the article: Reuters . "The healthcare landscape is rapidly changing, and Centene's mission to transform the health of our communities one member at a time has never been more relevant. Chief Operating Officer. CENTENE IS COMMITTED TO CORPORATE SUSTAINABILITY . HealthCare Enterprises is a portfolio of high growth companies independent of Centene health plans, designing differentiated platform capabilities and delivering industry-leading products and . A copy of the press release announcing the events described in Item 5.02 above In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in completed and future acquisitions, including statements about the impact of our recently completed acquisition of Magellan Health (the Magellan Acquisition), other recent and future acquisitions and dispositions, investments and the adequacy of our available cash resources. Subscriber only . Sarah London, Chief Executive Officer, Centene Corporation Sarah London leads Centene, a diversified enterprise that has grown to become the leading provider of government-sponsored healthcare, with an established expertise serving lower income and medically complex populations. As at CENTENE CORP, made $0 in total compensation. In announcing the 41-year-old Londons elevation to Centenes top job, the company described her as at the forefront of innovation in healthcare . Her strategic thinking, fresh perspective and diverse experience make her the natural leader to harness the potential of Centene," Centenes Acting Chairman, James Dallas said in a statement. Sarah London Work Experience and Education. "Sarah has infused an innovative mindset across the enterprise in her relentless effort to improve Centene's capabilities to provide the highest quality of care for our members. ", "I am honored and humbled to have been selected as the next CEO of Centene and to work alongside extraordinary colleagues to provide quality healthcare to over 26 million Americans," said Ms. London. Ms. London previously served as the Company's Senior Vice President of Technology Innovation and Modernization, responsible for enterprise-wide technology strategy and execution with a focus on next-generation products and services. "The healthcare landscape is rapidly changing, and Centene's mission to transform the health of our communities one member at a time has never been more relevant, London added. Prior to Centene, she was an Operating Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. The oldest executive at Centene Corp. is RobertDitmore, 86, who is the Presiding Independent Director. New SEC Custody Rule Would Scare Away Qualified Custodians: Lawyer, Why Secure 2.0s RMD Delay Matters Even More Than Many Think, Long COVID Correlates With High Mortality: Health Insurer, Antitrust Suit Challenging Schwab-TD Ameritrade Deal Can Proceed, Judge Rules, When Medicare Enrollees Return to Work: A Medicare Customer Q&A, How to Attract the Best, Most Overlooked Clients, Divorce Looks Like Forced Early Retirement for Many Wealthy Women, Advisor Says, Advisor Speaks Out on Industry's Treatment of Women. Mizuho Securities Adjusts Centene Price Target to $80 From $92, Maintains Neutral Ratin.. North American Morning Briefing: Stock Futures -3-, Centene Addresses Social Isolation in Schools with National No One Eats Alone Day. Women represent 76% of our employees and 65% of employees in supervisory positions. Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox. Centene Names Venture Capital Veteran CEO, Life Health > Health Insurance > Medicare Planning, News January 12, 2022, 8:01 AM Sarah London, Vice Chairman of Centene, joins Yahoo Finance Live to talk about Centene's health care initiatives, CMS changes, and how they are handling COVID-19. As Centenes first woman CEO, London has been instrumental in helping the insurer boost earnings and grow its core lines of business. "I am honored and humbled to have been selected as the next CEO of Centene and to work alongside extraordinary colleagues to provide quality healthcare to over 26 million Americans," London said in a statement. Previously, she served as Chief Product Officer for Optum Analytics and Vice President of Client Services & Operations at Humedica. She said about her new role that the health care landscape is changing rapidly. The board of Centene has picked Sarah London an executive with roots in venture capital and talent. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. Net income dropped 26% to $1.3 billion. Centenes large size and central role in behavioral care management mean that it could affect what retirement planning clients Medicare plans look like, what the plans will cost, and how both working-age and older clients plans cover mental health care, behavioral health care and other types of care. Michael built one of the great success stories in American business, and his commitment to providing affordable, high-quality healthcare to our fellow citizens will remain a bedrock of this Company going forward," said Ms. London. Centene Corporation, (d) Election of Sarah London as a Member of the Board, ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders.". Our local approach allows us to help members access high-quality, culturally sensitive healthcare services. .advancing integrated, value-based care models through the development and application of data-driven insights and technology. Londons promotion to CEO is effective immediately, Centene said. . ", "I am honored and humbled to have been selected as the next CEO of Centene and to work alongside extraordinary colleagues to provide quality healthcare to over 26 million Americans," said Ms. London. Will Others Follow? Centene Corporation 184,800 followers 5mo . Effective with her election as Vice Chairman, Ms. London will have a base salary of $1,250,000 and a target annual cash bonus of 150% of her base salary. Centene Salaries trends. Article content. London, who became. Ms. London joined Centene in 2020 as Senior Vice President of Technology Innovation and Modernization, overseeing the companys enterprise-wide technology strategy with a focus on next-generation products and services. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Company, and in her management role was responsible for a portfolio of companies independent of Centene's health plans, designing differentiated platform capabilities, and delivering industry-leading products and services to third-party customers. Magna Cum Laude in History & Literature from Harvard College, where she played Division I tennis. In her past career Ms. London held the position of Vice President-Client Management & Operations at Humedica, Inc., Senior Principal & Partner at Optum Venture Management LLC and Head-Marketing & Media Relations at Omega Protein Corp. Russia's war on Ukraine latest: Putin casts war as battle for nation's survival, India FM Jaishankar says Soros dangerous, debate needed on democracy, Buffett's Berkshire profit falls on investments, currencies, Bill Gates buys Heineken stake, despite saying he's 'not a big beer drinker', Elon Musk recruits team to develop OpenAI rival - The Information, Hedge fund manager Chris Hohn demands Airbus drop Atos deal - letter, Elon Musk's challenge: Stay ahead of the competition, ISS urges Apple shareholders to vote for CEO Tim Cook, other execs' pay packages, Elon Musk accuses media of racism after newspapers drop 'Dilbert' cartoon, French media billionaire Niel fails with bid for TNT television frequence - Arcom, Centene Reports Mixed Fourth-Quarter Results, But Lifts Full-Year Premium, Service Revenue Outlook, Transcript : Centene Corporation, Q4 2022 Earnings Call, Feb 07, 2023, Transcript : Centene Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 07:30 AM, Centene Affirms 2022 Guidance, Offers Mixed 2023 Outlook, Transcript : Centene Corporation - Analyst/Investor Day, Centene Corporation Announces Management Changes. Ken Fasola. March 22 (Reuters) - U.S health insurer Centene Corp CNC.N on Tuesday named Vice Chairman Sarah London as its new chief executive officer, effective immediately. Centene Corporation announced that Sarah London, vice chairman of Centene, has been appointed chief executive officer, effective immediately, succeeding Michael Neidorff. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company. Musk Made a Mess at Twitter. Biography. Before joining Centene in 2020, Ms. London was a Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Brent Layton, President and Chief Operating Officer of Centene, stated, "Sarah brings a tremendous skillset to the leadership of Centene Corporation, and I'm excited to partner closely with her as Centene begins our journey into the next era of our history. Employees in the business development department receive relatively high salaries as well, where wages average $91,494 per year. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. You may also find the annual proxy statement by going directly to the company's website. President. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Together, we can deliver innovative, integrated, and equitable care that meets our members where they live and exceeds their expectations. UnitedHealths Optum unit acquired Humedica in 2013. Centene Corporation's highest paid executives include: Jesse Hunter $4,442,868 and Keith Williamson $3,049,469. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, afterthe date hereof.
Anderson Laws Funeral Home Harlan, Ky,
Articles S